Successful pregnancy outcome following maternal intravenous immunoglobulin treatment in a woman with recurrent perinatal haemochromatosis

Prenatal Diagnosis

Volumn 26, Issue 13, 2006, Pages 1256-1259

  Venkat Raman, Narayanaswamy ^a,b   Venkata Krishnan, Radha Y ^a   Howarth, Edmund S ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Fetal hydrops; Immunoglobulin treatment; Liver failure; Neonatal haemochromatosis; Perinatal haemochromatosis

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMOXICILLIN; CEFUROXIME; DEFEROXAMINE; FERRITIN; FLUCONAZOLE; IMMUNOGLOBULIN; VITAMIN K GROUP;

ADULT; ANAMNESIS; ANAPHYLAXIS; APGAR SCORE; ARTICLE; CASE REPORT; CESAREAN SECTION; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; FERRITIN BLOOD LEVEL; FETUS; FETUS HYDROPS; FEVER; FOLLOW UP; HEADACHE; HEALTH STATUS; HEMOCHROMATOSIS; HISTOPATHOLOGIC SKIN REACTION; HUMAN; HUMAN TISSUE; INFANT; INFLAMMATION; LIP BIOPSY; LIVER FAILURE; LIVER FUNCTION; MALE; NAUSEA; OLIGOHYDRAMNIOS; OUTCOME ASSESSMENT; PERINATAL DEATH; PERINATAL MORBIDITY; PREGNANCY OUTCOME; PRENATAL SCREENING; PRIORITY JOURNAL; RECURRENT DISEASE; SEPSIS; SHIVERING; SIDEROSIS; TACHYCARDIA; TREATMENT DURATION;

ACETYLCYSTEINE; ADULT; DEFEROXAMINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FERRITINS; FETAL DISEASES; FREE RADICAL SCAVENGERS; GESTATIONAL AGE; HEMOCHROMATOSIS; HUMANS; HYDROPS FETALIS; INFANT, NEWBORN; LIVE BIRTH; LIVER FAILURE, ACUTE; PREGNANCY; RECURRENCE; TREATMENT OUTCOME; VITAMIN E; VITAMIN K;

EID: 33845952686     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1601     Document Type: Article

References (10)

1. Colletti RB, Clemmons JJ. 1988. Familial neonatal hemochromatosis with survival. J Pediatr Gastroenterol Nutr 1907: 39-45.
2. Kassem E, Dolfin T, Litmanowitz I, Regev R, Arnon S, Kidron D. 1999. Familial perinatal hemochromatosis: a disease that causes recurrent non-immune hydrops. J Perinat Med 1927: 122-127.
3. Kelly AL, Lunt PW, Rodrigues F, et al. 2001. Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism. J Med Genet 1938: 599-610.
4. Knisely AS, O'Shea PA, Stocks JF, Dimmick JE. 1988. Oropharyngeal and upper respiratory tract mucosal-gland siderosis in neonatal hemochromatosis: an approach to biopsy diagnosis. J Pediatr 113: 871-874.
5. Murray KF, Kowdley KV. 2001. Neonatal hemochromatosis. Pediatrics 108: 960-964.
6. Rand EB, Whitington PF. 1992. Successful orthotopic liver transplantation in two patients with liver failure due to sclerosing cholangitis with Langerhans cell histiocytosis. J Pediatr Gastroenterol Nutr 1915: 202-207.
7. Simon HU, Spath PJ. 2003. IVIG-mechanisms of action. Rev Allergy 1958: 543-552.
8. van Mirre E, Teeling JL, van der Meer JW, Bleeker WK, Hack CE. 2004. Monomeric IgG in intravenous Ig preparations is a functional antagonist of FcgammaRII and FcgammaRIIIb. J Immunol 173: 332-339.
9. Verloes A, Temple IK, Hubert AF, et al. 1996. Recurrence of neonatal haemochromatosis in half sibs born of unaffected mothers. J Med Genet 1933: 444-449.
10. Whitington PF, Hibbard JU. 2004. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet 364: 1690-1698.